Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Symetria Health is a healthcare services company that provides comprehensive outpatient treatment for substance use disorders, with a primary focus on opioid addiction. The company operates a network of clinics under the brand Symetria Recovery, utilizing a proprietary "Symetria Method" that integrates Medication-Assisted Treatment (MAT) with intensive behavioral therapy and psychiatric support. By combining medical interventions like methadone or buprenorphine with clinical counseling, the company aims to improve long-term recovery outcomes and reduce relapse rates. Symetria's model is designed to offer a higher level of care than traditional outpatient programs while maintaining the flexibility of an office-based setting. In October 2023, the company was acquired by BayMark Health Services, further consolidating its position within the North American addiction treatment market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Symetria Health.